Clinical Trial Update: Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tislelizumab for stage III non-small cell lung cancer after neoadjuvant therapy, with optional bevacizumab and definitive concurrent ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage III Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING